Cipro Class Action Antitrust Settlement

Class Members Eligible for Cipro Class Action Lawsuit Settlement

All persons and entities who indirectly purchased the prescription antibiotic drug Cipro in California between January 8, 1997 and October 31, 2004 intended for consumption by themselves, their families, or their members, participants, employees or insureds from any of the following Defendants: Bayer Corporation and Bayer AG; Barr Laboratories, Inc.; Hoechst Marion Roussel, Inc.; Watson Pharmaceuticals, Inc.; and The Rugby Group, Inc. (collectively, the “Defendants”). The Class includes both consumers and third-party payors. If you fall within these class qualifications then can be eligible for the Cipro Class Action Lawsuit Settlement.

Class Action Claims Recovery is here to determine your verification status and file on your behalf, so you may recover proper damages from the Cipro Class Action Lawsuit Settlement.

Cipro Class Action Lawsuit Settlement Case History:

In 2000, a class action was filed in the Superior Court of California against the Defendants alleging they colluded to block consumer access to affordable, generic versions of Cipro by agreeing not to compete with each other and keep generic, lower-cost, versions of Cipro off the market. In June 2013 a $74,000,000 class action settlement with Bayer Corporation and Bayer AG (“Bayer”) was reached. On November 18, 2013, the Superior Court granted final approval to the settlement with Bayer. Defendants, including Bayer, deny these claims and say their conduct was legal. The Defendants other than Bayer have not entered into settlements in these cases.

Definition of Cipro As Included in the Antitrust Settlement:

Cipro is an antibiotic drug prescribed by doctors. Cirpo is used to treat a wide variety of infections, including infections of bones and joints, endocarditis, gastroenteritis, malignant otitis externa, respiratory tract infections, cellulitis, urinary tract infections, prostatitis, anthrax, and chancroid.

Definition Third Party Payor Included in the Cipro Class Action Antitrust Settlement:

A Third-Party Payor Class Member is an entity that is a party to a contract, issuer of a policy, or sponsor of a plan, and that must pay or reimburse all or part of the cost of Cipro dispensed to its California members. Third-Party Payor Class Members could include:

  • Entities with self-funded plans that contract with a health insurance company or other firm to serve as a third-party claims administrator to administer such entities’ prescription drug benefits; or
  • Insurance companies, union health and welfare benefit plans, and other organizations that paid for all or part of a Cipro prescription obtained by one of their California members between January 8, 1997 and October 31, 2004.

Required Action Step:

Get Started by providing your details, then upon execution of our service agreement, CAC Recovery will file your claims and assist you in gathering the specific documentation necessary to maximize your Cipro Class Action Lawsuit Antitrust Settlement recovery.

Our Class Action Settlement Services:

CAC Recovery navigates the complex intricacies of the Cipro Antitrust Settlement claims filing process to help businesses maximize their settlement recoveries.

Our class action settlement services include:

  • Identifying class action claims where businesses may be eligible to file
  • Filing the class action claim with supporting documentation
  • Interacting with the class action Claims Administrator
  • Providing updates on class action claim settlements status
  • Resolving Claims Administrator questions on claims
  • Reviewing the recovery to assure the correct compensation claims amount has been received

Our Guarantee: We Get Paid When You Recover – No hidden charges or up-front fees. We provide our class action settlements services based on a contingency fee.

Getting Started is easy! We’ll first have you fill out our Get Started form and a CAC representative will contact you within 24 hours to review your eligibility and walk you through the claims process.